Low Molecular Weight Heparin Significantly Reduces Embolisation After Carotid Endarterectomy - A Randomised Controlled Trial

European Journal of Vascular and Endovascular Surgery

Volumn 37, Issue 6, 2009, Pages 633-639

  McMahon, G S ^a   Webster, S E ^a   Hayes, P D ^a   Jones, C I ^a   Goodall, A H ^a   Naylor, A R ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Anticoagulation; Antiplatelet drugs; Aspirin; Carotid endarterectomy

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; DALTEPARIN; DEXTRAN 40; HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY CLAMP; ARTERY EMBOLISM; ARTICLE; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; EMBOLISM PREVENTION; EX VIVO STUDY; FEMALE; HEPARINIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SURGICAL MORTALITY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TREATMENT RESPONSE;

ADENOSINE DIPHOSPHATE; AGED; ANTICOAGULANTS; ARACHIDONIC ACID; ASPIRIN; CAROTID ARTERY DISEASES; DALTEPARIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENDARTERECTOMY, CAROTID; FEMALE; HEMORRHAGE; HEPARIN; HUMANS; INFUSIONS, INTRAVENOUS; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; ODDS RATIO; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RISK ASSESSMENT; STROKE; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 67349125887     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.02.009     Document Type: Article

References (30)

1. Lennard N., Smith J.L., Dumville J., Abbott R., Evans D.E., London N.J.M., et al. Prevention of postoperative thrombotic stroke after carotid endarterectomy: the role of transcranial Doppler ultrasound. J Vasc Surg 26 (1997) 579-584
2. Riles T.S., Imparato A.M., Jacobowitz G.R., Lamparello P.J., Giangola G., Adelman M.A., et al. The cause of peri-operative stroke after carotid endarterectomy. J Vasc Surg 19 (1994) 206-214
3. Radak D., Popovic A., Radicevic S., Neskovic A., and Bojic M. Immediate reoperation for perioperative stroke after 2250 carotid endarterectomies: differences between intraoperative and early postoperative stroke. J Vasc Surg 30 (1999) 245-251
4. Gaunt M.E., Smith J.L., Martin P.J., Ratliff D.A., Bell P.R.F., and Naylor A.R. A comparison of quality control methods applied to carotid endarterectomy. Eur J Vasc Endovasc Surg 11 (1996) 4-11
5. Levi C., O'Malley H., Fell G., Roberts A., Hoare M., Royle J., et al. Transcranial Doppler detected cerebral microembolism following carotid endarterectomy. High microembolic signal loads predict postoperative cerebral ischaemia. Brain 120 (1997) 621-629
6. Hayes P., Lloyd A., Lennard N., Wolstenholme J., London N., Bell P., et al. Transcranial Doppler-directed Dextran-40 therapy is a cost-effective method of preventing carotid thrombosis after carotid endarterectomy. Eur J Vasc Endovasc Surg 19 (2000) 56-61
7. Hayes P.D., Box H., Tull S., Bell P.R.F., Goodall A.H., and Naylor A.R. Patients' thromboembolic potential after carotid endarterectomy is related to the platelets' sensitivity to adenosine diphosphate. J Vasc Surg 38 (2003) 1226-1231
8. Payne D.A., Jones C.I., Hayes P.D., Thompson M.M., London N.J., Bell P.R.F., et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation 109 (2004) 1476-1481
9. Webster S.E., Payne D.A., Jones C.I., Hayes P.D., Bell P.R.F., Goodall A.H., et al. Anti-platelet effect of aspirin is substantially reduced after administration of heparin during carotid endarterectomy. J Vasc Surg 40 (2004) 463-468
10. Payne D.A., Jones C.I., Hayes P.D., Webster S.E., Naylor A.R., and Goodall A.H. Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance?. Thromb Haemost 92 (2004) 89-96
11. Roth G.J., Stanford N., and Majerus P.W. Acetylation of prostaglandin synthase by aspirin. Proceedings of the National Academy of Sciences of USA 72 (1975)
12. Knight C., Panesart M., Wilson D., Patrineli A., Chronos N., Wright C., et al. Increased platelet responsiveness following coronary stenting: heparin as a possible aetiological factor in stent thrombosis. Eur Heart J 19 (1998) 1239-1248
13. Hirsh J., and Raschke R. Heparin and low-molecular-weight heparin: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126 (2004) 188-203
14. Walenga J., Prechel M., Jeske W., and Bakhos M. Unfractionated heparin compared with low-molecular-weight heparin as related to heparin-induced thrombocytopenia. Curr Opin Pulm Med 11 (2006) 385-391
15. Ringelstein E., Droste D., Babikian V., E D.H., Grosset D., Kaps M., et al. Consensus on microembolus detection by TCD. International consensus group on microembolus detection. Stroke 29 (1998) 725-729
16. Naylor A. Making carotid surgery safer. British Medical Bulletin 56 (2000) 539-548
17. Gum P., Kottke-Marchant K., Poggio E., Gurm H., Welsh P., Brooks L., et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 41 (2001) 961-965
18. Engelter S., and Lyrer P. Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy. Stroke 35 (2004) 1227-1228
19. Murray G. Heparin in surgical treatment of blood vessels. Arch Surg 40 (1940) 307-325
20. Samama M., and Gerotziafas G. Comparative pharmacokinetics of LMWHs. Semin Thromb Hemost 26 Suppl. (2000) 31-38
21. ENOXACAN Study Group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. Br J Surg 84 (1997) 1099-1103
22. Norgren L., and on behalf of the Swedish Enoxa Study Group. Can low molecular weight heparin replace unfractionated heparin during peripheral arterial reconstruction? An open label prospective randomized controlled trial. J Vasc Surg 39 (2004) 977-984
23. Eika C. The platelet aggregating effect of eight commercial heparins. Scand J Haematol 9 (1972) 430-482
24. Chong B., and Ismail F. The mechanism of heparin-induced platelet aggregation. Eur J Haematol 43 (1989) 245-251
25. Xiao Z., and Theroux P. Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation 97 (1998) 251-256
26. Horne III M., and Chao E. The effect of molecular weight on heparin binding to platelets. Br J Haematol 74 (1990) 306-312
27. Montalescot G., Bal-dit-Sollier C., Chibedi D., Collet J., Soulat T., Dalby M., et al. Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study). Am J Cardiol 91 (2003) 925-930
28. Naylor A.R., Hayes P.D., Allroggen H., Lennard N., Gaunt M.E., Thompson M.M., et al. Reducing the risk of carotid surgery: a 7-year audit of the role of monitoring and quality control assessment. J Vasc Surg 32 (2000) 750-759
29. Hayes P.D., Payne D., Lloyd A.J., Bell P.R.F., and Naylor A.R. Patients' thromboembolic potential between bilateral carotid endarterectomies remains stable over time. Eur J Vasc Endovasc Surg 22 (2001) 496-498
30. Rothwell P., Slattery J., and Warlow C. Clinical and angiographic predictors of stroke and death from carotid endarterectomy: systematic review. BMJ 315 (1997) 1571-1577